Isomorphic Labs Secures $600 Million To Revolutionize Drug Discovery With AI

Isomorphic Labs, the trailblazing AI-driven drug discovery startup, has successfully raised $600 million in its inaugural funding round. The Series A round, spearheaded by Thrive Capital, also saw continued backing from Alphabet’s Google Ventures, marking a significant milestone for the company.

Why This Matters

With AI rapidly becoming the core of innovation in nearly every tech sector, Isomorphic Labs is tapping into the booming intersection of artificial intelligence and pharmaceuticals. As demand for AI-powered solutions surges, particularly in drug development, this latest investment highlights the growing importance of AI in reshaping the life sciences industry.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The Backstory

Founded in 2021, Isomorphic Labs emerged from Google’s renowned AI research division, DeepMind. The company builds on DeepMind’s groundbreaking advancements, including the Nobel-winning “AlphaFold” model, which accurately predicts protein structures—critical to understanding diseases and developing new drugs. Isomorphic’s work represents the next frontier in AI-powered medicine.

Looking Ahead

The newly secured capital will fuel the company’s R&D ambitions and accelerate its talent acquisition. Founder and CEO Demis Hassabis, who also heads DeepMind, has ambitious plans. He aims for Isomorphic Labs to have AI-designed drugs entering clinical trials by the end of 2025—a timeline that underscores both the company’s potential and the immense promise of AI in revolutionizing drug discovery.

This $600 million funding round not only signals strong investor confidence but also cements Isomorphic Labs’ position at the forefront of the AI pharmaceutical revolution.

The Future Forbes Realty Global Properties

Bank Of England Holds Rates At 3.75% In Split Vote As Inflation Risks Rise

by THEFUTURE.TEAM

September 17, 2026

The Bank of England kept its benchmark interest rate at 3.75% on Thursday, but the decision was not unanimous. In a 6-3 vote, the Monetary Policy Committee kept rates unchanged, while three members backed a 25-basis-point increase to 4%. Renewed energy price pressures have added to concerns that inflation could remain elevated.

Inflation Pressures Remain

Policymakers said inflation “is likely to rise further over coming quarters,” citing higher and more volatile crude oil and refined energy prices since the conflict began.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

So far, there has been “little evidence” of significant second-round effects, such as broader wage and price increases. Inflation risks, however, are now “tilted to the upside” and have increased since the July Monetary Policy Report.

Energy Prices Add To Inflation Risks

Brent crude has risen 36% since July, reaching $106 a barrel on Sept. 14, while UK wholesale gas prices increased 78% to 207 pence per therm.

Higher energy costs can feed into transport, production and household expenses, raising costs across supply chains. Refinery pressures have also pushed crack spreads, the difference between refined fuel and crude prices, well above pre-conflict levels.

Economy Shows Resilience

Despite the inflation risks, UK economic activity has held up slightly better than the Bank expected. A softer labor market and higher borrowing costs are expected to help reduce inflation over time.

Previous monetary tightening is still working through the economy, according to policymakers. So far, the latest energy shock has not produced clear evidence of a broader wage-price spiral.

Major Central Banks Take Different Paths

The decision comes during a busy period for global monetary policy. The Federal Reserve raised rates Wednesday to 3.75%-4% in its first increase since 2023, while the European Central Bank recently lifted its deposit rate to 2.5%.

The Bank of Japan is due to announce its decision Friday, with markets expecting a rate increase. Thursday’s split vote shows that pressure for tighter policy remains within the Bank of England’s Monetary Policy Committee.

Breaking news